Sublingual immunotherapy and patient informed consent

Rafał Pawliczak

doi:10.5114/pja.2019.86347

eISSN: 2391-6052
ISSN: 2353-3854

Alergologia Polska - Polish Journal of Allergology

Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2019
vol. 6

Send email

Copy url:

abstract:

Guidelines/recommendations

Sublingual immunotherapy and patient informed consent

Rafał Pawliczak

¹

Zakład Immunopatologii, Katedra Alergologii, Immunologii i Dermatologii, Uniwersytet Medyczny w Łodzi

Alergologia Polska – Polish Journal of Allergology 2019; 6, 2: 43-48

DOI: https://doi.org/10.5114/pja.2019.86347

Online publish date: 2019/07/09

View full text Get citation

PlumX metrics:

Sublingual allergen immunotherapy is a moderate risk procedure. Although the safety data collected so far indicating that it might be relatively safe, it is still exposure to high does of allergens administered in patients’ home, without direct supervision from medical professionals. Therefore, obtaining an informed and written patients informed consent prior the beginning is mandatory. The short chapter deals with legal aspect of sublingual allergen immunotherapy consent. It also delivers examples of the informed consent form to be used in an allergist office.

keywords:

Sublingual immunotherapy and patient informed consent

Rafał Pawliczak 1

informed consent, sublingual immunotherapy

Rafał Pawliczak

¹